MedPath
HSA Approval

LOTYRO 25 ERLOTINIB FILM COATED TABLETS 25MG

SIN17082P

LOTYRO 25 ERLOTINIB FILM COATED TABLETS 25MG

LOTYRO 25 ERLOTINIB FILM COATED TABLETS 25MG

September 11, 2024

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L01EB02

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

MSN Laboratories Private Limited

Active Ingredients

Erlotinib hydrochloride eqv Erlotinib

25.00mg

Erlotinib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LOTYRO 25 ERLOTINIB FILM COATED TABLETS 25MG - HSA Approval | MedPath